Answers are grounded in this paper and cite their sources.
Atherosclerosis is the leading cause of death in developed countries. High density lipoproteins (HDL) cholesterol level correlates inversely with the risk of cardiovascular diseases. Thus, HDL has obtained lots of interest for drug development. In this review, we summarized the mechanisms for the antiatherogenic function of HDL, current HDL-based drugs in clinical use and the future direction for HDL-based therapy development.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: